SNPS

430.1401.81%

Weekly Recap | Synopsys +0.9%, most brokers rate it buy

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Synopsys (SNPS) rose 0.9% this week (7–13 September 2026, four trading days) to close at $397.38, from a previous close of $393.84. The S&P 500 fell 0.8% over the same period, so SNPS outperformed the benchmark by roughly 1.7 percentage points. Trading was choppy. The stock opened Tuesday at $396.82, touched a weekly high of $405.80, and then pulled back to finish at $392.03. Wednesday saw the weekly low of $387.60. SNPS steadied over the next two sessions and ended Friday at $397.38.

The Week

Synopsys (SNPS) rose 0.9% this week (7–13 September 2026, four trading days) to close at $397.38, from a previous close of $393.84. The S&P 500 fell 0.8% over the same period, so SNPS outperformed the benchmark by roughly 1.7 percentage points. Trading was choppy. The stock opened Tuesday at $396.82, touched a weekly high of $405.80, and then pulled back to finish at $392.03. Wednesday saw the weekly low of $387.60. SNPS steadied over the next two sessions and ended Friday at $397.38. Weekly amplitude was 4.59%, and average daily volume was about 1.6m shares, in line with the median for the period.\n\n## Key Events

Morgan Stanley upgraded Synopsys to a Buy on Tuesday, the most direct company-specific headline of the week. On Saturday, Synopsys announced it had joined Arm Total Design for Physical AI, a programme aimed at advancing autonomous systems; the move reinforces SNPS’s position in the AI chip design tooling ecosystem. On the industry front, a 9 September report said OpenAI is pushing cost-per-task pricing as it expands into chip design and finance, which put EDA tool demand back into the conversation. Several analyst columns during the week also listed SNPS among growth names with meaningful upside, though these read more as sentiment flow than hard news. On Friday, Synopsys shares outperformed peers during the trading day, a market note worth keeping in perspective.\n\n## Analyst Ratings

Among 27 institutions covering Synopsys, 17 rate it buy and 5 rate it overweight; 2 are neutral, 1 underweight, and 2 have no opinion. There are no sell ratings. The consensus recommendation is strong buy, with 25 institutions on the positive side of the ledger. The consensus target price is $545.93385, implying about 37.4% upside from the current $397.38. The target range runs from $414.770 to $633.000, a spread of more than $200 that signals disagreement on the medium-term path. Within the application software industry, Synopsys ranks 15th out of 199 covered names.\n\n## The Week Ahead

Next week’s macro calendar is dense. The key release is US retail sales on Wednesday, 16 September: retail sales ex-autos came in at -0.3 last month with a 0.6% estimate, and retail control printed -0.4 with a 0.4% forecast. A stronger print could shift rate-path expectations. The same day brings import prices and the NAHB housing market index. On Tuesday, 15 September, the New York Fed manufacturing index is due, with a prior reading of 20.6 and a 14.75 estimate. Synopsys has no earnings scheduled, but semiconductor and design software names are sensitive to macro signals on consumption and corporate capex, so the retail and manufacturing data are the ones to watch.\n\n## In Short

The week leaves a mixed picture. Ratings skew positive, with a consensus target around 37% above spot and an industry ranking near the top. Valuation sits at roughly 70.7x earnings, a high level by any standard. On the latest trading day, large-lot flow pointed to net selling while small-lot flow pointed to net buying, suggesting divergence between institutional and retail positioning. Price-wise, SNPS held a positive weekly close but did not reclaim the weekly high, remaining in the middle of a range bounded by the 60-day high of $479.80 and the July low of $366. The open questions are whether next week’s retail data can support enterprise IT spending expectations, and whether the Arm programme develops into a lasting catalyst.\n\nThis article is generated by LongbridgeAI from market data, for information only and not investment advice.

Source: Weekly Review The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.